Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin versus corticosteroid plus lidocaine for rotator cuff tendinopathy
IRCT20240623062220N1Phase 3Completed
- Sponsor
- Aja University of Medical Sciences
- Start
- Nov 2024
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in shoulder tendinopathy comparing Botulinum toxin arm with Corticosteroid plus lidocaine arm (2 arms). Primary endpoints: Shoulder joint range of motion at 3 months, Pain intensity at 3 months and 1 more. Started Nov 2024; status: completed.
02
Drugs
neuronoxlidocaine
03
Conditions
shoulder tendinopathy
Beyond the preview
Go deeper on IRCT20240623062220N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240623062220N1.